Regarding 'HPV vaccination for cervical cancer prevention is not cost-effective in Japan'

Asian Pac J Cancer Prev. 2015;16(6):2583-4. doi: 10.7314/apjcp.2015.16.6.2583.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Cost-Benefit Analysis
  • Humans
  • Japan
  • Papillomavirus Infections / prevention & control*
  • Papillomavirus Vaccines
  • Uterine Cervical Neoplasms / prevention & control*
  • Vaccination

Substances

  • Papillomavirus Vaccines